SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-07-013171
Filing Date
2007-03-16
Accepted
2007-03-16 16:24:41
Documents
20
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 v068370_10k.htm 10-K 2888737
2 GRAPHIC comparisongraph.jpg GRAPHIC 35145
3 v068370_ex10-25.htm EX-10.25 1402
4 GRAPHIC v068370_ex10-25x1x1.jpg GRAPHIC 80393
5 GRAPHIC v068370_ex10-25x2x1.jpg GRAPHIC 129783
6 GRAPHIC v068370_ex10-25x3x1.jpg GRAPHIC 147040
7 GRAPHIC v068370_ex10-25x4x1.jpg GRAPHIC 119936
8 GRAPHIC v068370_ex10-25x5x1.jpg GRAPHIC 95940
9 v068370_ex10-26.htm EX-10.26 1306
10 GRAPHIC v068370_ex10-26x1x1.jpg GRAPHIC 81438
11 GRAPHIC v068370_ex10-26x2x1.jpg GRAPHIC 134298
12 GRAPHIC v068370_ex10-26x3x1.jpg GRAPHIC 146105
13 GRAPHIC v068370_ex10-26x4x1.jpg GRAPHIC 136986
14 GRAPHIC v068370_ex10-26x5x1.jpg GRAPHIC 100249
15 v068370_ex21-1.htm EX-21.1 8856
16 v068370_ex23-1.htm EX-23.1 15800
17 v068370_ex31-1.htm EX-31.1 18136
18 v068370_ex31-2.htm EX-31.2 20316
19 v068370_ex32-1.htm EX-32.1 7261
20 v068370_ex32-2.htm EX-32.2 7625
  Complete submission text file 0001144204-07-013171.txt   4635921
Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Filer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30929 | Film No.: 07700450
SIC: 2834 Pharmaceutical Preparations